Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.900
+0.030 (1.60%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cardiol Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 153 | 54 | 32 | 112 | 72 | 91 | |
Market Cap Growth | 140.96% | 67.34% | -71.06% | 56.56% | -21.55% | 23.29% | |
Enterprise Value | 136 | 24 | -16 | 90 | 59 | 84 | |
Last Close Price | 1.90 | 0.84 | 0.51 | 1.85 | 2.18 | 3.54 | |
PE Ratio | - | -2.55 | -1.39 | -3.20 | -4.02 | -8.66 | |
PS Ratio | - | - | - | 1803.25 | - | - | |
PB Ratio | 12.26 | 2.54 | 0.84 | 1.86 | 6.88 | 8.08 | |
P/FCF Ratio | -8.72 | -2.84 | -1.61 | -6.03 | -9.96 | -10.04 | |
P/OCF Ratio | -8.73 | -2.85 | -1.61 | -6.03 | -10.01 | -10.41 | |
EV/Sales Ratio | - | - | - | 1441.08 | - | - | |
EV/EBITDA Ratio | -5.05 | -1.06 | 0.52 | -2.95 | -3.66 | -9.23 | |
EV/EBIT Ratio | -5.03 | -1.05 | 0.52 | -2.94 | -3.62 | -9.13 | |
EV/FCF Ratio | -7.41 | -1.24 | 0.79 | -4.82 | -8.17 | -9.20 | |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | |
Debt / FCF Ratio | -0.01 | -0.01 | 0.00 | 0.00 | -0.02 | -0.02 | |
Asset Turnover | - | - | - | 0.00 | - | - | |
Quick Ratio | 2.24 | 4.24 | 6.11 | 7.29 | 5.66 | 11.42 | |
Current Ratio | 2.39 | 4.36 | 6.27 | 7.53 | 5.94 | 20.81 | |
Return on Equity (ROE) | -108.43% | -69.93% | -48.16% | -70.69% | -147.74% | -74.08% | |
Return on Assets (ROA) | -54.15% | -37.71% | -34.47% | -46.58% | -82.38% | -36.99% | |
Return on Capital (ROIC) | -73.24% | -46.14% | -40.17% | -53.83% | -91.42% | -39.75% | |
Earnings Yield | -14.01% | -39.19% | -70.37% | -22.28% | -22.60% | -11.55% | |
FCF Yield | -10.15% | -35.17% | -62.10% | -16.58% | -10.04% | -9.96% | |
Buyback Yield / Dilution | -4.44% | -3.13% | -44.61% | -44.77% | -15.63% | -67.97% | |
Total Shareholder Return | -4.44% | -3.13% | -44.61% | -44.77% | -15.63% | -67.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.